Cholesteryl ester transfer protein; An enigmatic protein

Hormone Research in Paediatrics

Volumn 45, Issue 3-5, 1996, Pages 238-244

  Moulin, Philippe ^a  

^a Hopital de l'Antiquaille   (France)

Author keywords

Atherosclerosis; Cholesterol; Cholesteryl ester transfer protein; High density lipoproteins

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CAUCASIAN; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; DYSLIPIDEMIA; GENE MUTATION; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

ANIMALS; ARTERIOSCLEROSIS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; GLYCOPROTEINS; HUMANS; LIPOPROTEINS; MUTATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029987105     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184795     Document Type: Article

References (32)

1. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 1993:34:1255-1274.
2. Lagrost L: Regulation of the cholesteryl ester transfer protein activity: Review of in vitro and in vivo study. Biochim Biophys Acta 1994: 1215:209-236.
3. Day JR, Albers JJ, Lofton Day C, ct al: Complete cDNA encoding human phospholipid transfer protein from endothelial cells. J Biol Chem 1994;269:9388-9391.
4. Hesler CB, Swenson TL, Tall AR: Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem 1987:262:2275-2282.
5. Drayna D, Jarnagin AS, McLean J. ct al: Cloning and sequencing of the human cholesteryl ester transfer protein cDNA. Nature 1987:327: 632-634.
6. Jiang XJ, Moulin P, Quinet FR, Goldberg IJ, Yacoub LK, Agellon LB, Tall AR: Mammalian adipose tissue and muscle are major sources of lipid transfer protein niRNA. J Biol Chem 1991;266:4631-4639.
7. Quinet F, Yang TP, Marinos C, Tall AR: Inhibition of the cellular secretion of the cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA. J Biol Chem 1993:23:16891-16894.
8. Martin LI, Connelly PW, Nancoo D: Cholesteryl ester transfer protein and high density lipoprotein response to cholesterol feeding in men relationship to apo E genotype. J Lipid Res 1993:34:437-446.
9. Ginsberg UN, Karmally W, Siddiqui M. et al: Increases in dietary cholesterol in healthy young women. Arterioscler Thromb Vase Biol 1995:15:169-178.
10. Jiang XC, Agellon LB, Walsh A, Breslow JL, Tall AR: Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice: Dependence on natural llanking sequences. J Clin Invest 1992:90:1290-1295.
11. Wang S, Kussi P, Deng L, Tall A: Defective bind ng of neutral lipids by a carboxyl-terminal deletion mutant of cholesteryl ester transfer protein. Evidence for a carboxyl-terminal cholesteryl ester binding site essential for neutral lipid transfer activity. J Biol Chem 1995:270: 612-618.
12. Lagrost L, Gambert P, Dangremont V, Athias A, Lallcmant C: Role of cholesteryl ester transfer protein (CETP) in the HDLconversion process as evidenced by using anti-CETP monoclonal antibodies. J Lipid Res 1990:31:1569-1575.
13. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 1995;36:211-228.
14. Moulin P, Cheung MC, Austin AA, et al: Gender efTect on the distribution of the cholesteryl ester transfer protein in apolipoprotcin A-l-defincd lipoprotein subpopulations. J Lipid Res 1994:35:793-802.
15. Whitlock ME, Swenson TL, Ramakrishnan R. et at: Monoclonal antibody inhibition of cho-lcstcryl ester transfer protein activity in the rabbit, effects on lipoprotein composition and high density cholesteryl ester metabolism. J Clin Invest i 989:84:129-137.
16. Agcllon LB, Walsh A, Ilayck T, et al: Reduced high density lipoprotein cholesterol in human cholestcryl ester transfer protein transgenic mice. J Biol Chem 1991:266:10796-10801.
17. Hayek T, Chajck-Shaul T, Walsh A, Agellon LB, Moulin P, Tall AR: An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotcin A-I (apo Al) gene in transgenic mice results in a profound CETP-mediatcd depression of HDL cholesterol levels. J Clin Invest 1992:90:505-510.
18. Hayek T, Azrolan N, Verdery RB, et al: Hypertriglyceridemia and cholesteryl ester transfer protein expression interact to dramatically alter IIDL levels, particlc size and metabolism: Studies in transgenic mice. J Clin Invest 1993; 92:1143-1152.
19. Fazio S. Marotti KR, Lee YL, Castle CK, Melchior GW, Rail SC Jr: Coexprcssion of cholesteryl ester transfer protein and defective apolipoprotcin E in transgenic mice alters plasma cholcstcrol distribution. Implications for the pathogenesis of type III hyperlipoproteinemia. J Biol Chem 1994:269:32368-32372.
20. Tato F, Vega GL, Tall AR, Grundy SM: Relation between cholesteryl ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Artcriosclcr Thromb Vase Biol 1995:15:112-120.
21. Brown ML, Inazu A, Hcsler CB, et at: Molecular basis of lipid transfer protein deficiency in a family with increased high density lipoprotein. Nature 1989:342:448-451.
22. Inazu A, Jiang XJ, Haraki T, etal:Geneticcho-icsteryl ester transfer protein deficicncy caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholcstcrol. J Clin Invest 1994:94:1872-1882.
23. Funkc H, Wiebusch H, Fuer L: Identification of mutations in the cholesteryl ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation 1994;91(1241): 1296.
24. Cohen JC, Wang Z, Grundy S, Stoetz MR, Guerra R: Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 1994;94:2377-2384.
25. Kondo I, Berg K, Drayna D, Lawn R: DNA polymorphism at the locus for human cholcste-ryl ester transfer protein is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989;35:49-56.
26. McPherson R, Mann CJ, Tall AR, et al: Plasma concentrations of cholesteryl ester transfer protein in hyperlipidemia. relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 1991; 11:797-804.
27. Mann CJ, Yen FT, Grant AM, Bihain BE: Mechanism of plasma cholesteryl ester transfer in hyperlipidemia. J Clin Invest 1991:88: 2059-2066.
28. Arai T, Yamashita S, Mirano KI, et al: Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994; 14: 1129-1136.
29. Bagdade ID, Ritter MC, Subbaiah PV: Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 1991;21:161-167.
30. Moulin P, Appel GB, Ginsberg HN, Tall AR: Cholesteryl ester transfer protein is increased in patients with untreated nephrotic syndrome. J Lipid Res 1992:33:1817-1822.
31. Savolainen MJ, Hannuksela M, Seppaenen S, Kervinen K, Kesacniemi YA: Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest 1990:20:593-599.
32. Marotti KR, Castle CK, Boyle TP, Lin AH, Muray RW, Melchior GW: Severe atherosclerosis in transgenic mice expressing simian cho-lcsteryl ester transfer protein. Nature 1993; 364:73-75.